BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1567812)

  • 1. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
    Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
    Smith KJ; Pyrdol J; Gauthier L; Wiley DC; Wucherpfennig KW
    J Exp Med; 1998 Oct; 188(8):1511-20. PubMed ID: 9782128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province.
    Delfan N; Galehdari H; Ghanbari Mardasi F; Zabihi R; Latifi Pakdehi T; Seifi T; Majdinasab N
    Iran J Child Neurol; 2021; 15(3):35-46. PubMed ID: 34282361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
    Kaushansky N; Ben-Nun A
    Front Oncol; 2014; 4():280. PubMed ID: 25360418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of narcolepsy at Stanford University.
    Mignot EJ
    Immunol Res; 2014 May; 58(2-3):315-39. PubMed ID: 24825774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quest for better understanding of HLA-disease association: scenes from a road less travelled by.
    Holoshitz J
    Discov Med; 2013 Sep; 16(87):93-101. PubMed ID: 23998445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.
    Luckey D; Bastakoty D; Mangalam AK
    J Autoimmun; 2011 Sep; 37(2):122-8. PubMed ID: 21632210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.
    Mangalam A; Luckey D; Basal E; Jackson M; Smart M; Rodriguez M; David C
    J Immunol; 2009 Apr; 182(8):5131-9. PubMed ID: 19342694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.
    Mangalam A; Luckey D; Basal E; Behrens M; Rodriguez M; David C
    J Immunol; 2008 Jun; 180(11):7747-56. PubMed ID: 18490779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.
    Boyton RJ; Smith J; Jones M; Reynolds C; Ozerovitch L; Chaudhry A; Wilson R; Rose M; Altmann DM
    Clin Exp Immunol; 2008 Apr; 152(1):95-101. PubMed ID: 18241227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
    Oksenberg JR; Barcellos LF; Cree BA; Baranzini SE; Bugawan TL; Khan O; Lincoln RR; Swerdlin A; Mignot E; Lin L; Goodin D; Erlich HA; Schmidt S; Thomson G; Reich DE; Pericak-Vance MA; Haines JL; Hauser SL
    Am J Hum Genet; 2004 Jan; 74(1):160-7. PubMed ID: 14669136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis.
    Serjeantson SW; Gao X; Hawkins BR; Higgins DA; Yu YL
    Eur J Immunogenet; 1992; 19(1-2):11-9. PubMed ID: 1567812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
    Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
    Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in HLA-DR2-related DR,DQ haplotypes in eight populations of Asia-Oceania.
    Gao XJ; Serjeantson SW
    Immunogenetics; 1991; 34(6):401-8. PubMed ID: 1748488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
    Olerup O; Hillert J
    Tissue Antigens; 1991 Jul; 38(1):1-15. PubMed ID: 1926129
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.